Daniel J. Brennan Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 3 days, 1 hour ago
Daniel J. Brennan has an estimated net worth of at least $46.2 million*, as of Feb. 19, 2025. They own 225,808 shares of BSX stock. They have sold 424,403 shares of BSX stock since 2021, for an estimated $19.9 million.
Daniel J. Brennan $BSX SEC Form 4 Insider Trading
Daniel J. Brennan has filed a total of 14 insider trades in $BSX since 2021. Their most recent trade was a sale of 67,333 shares, made on Feb 19, 2025. Their largest trade was a sale of 75,610 shares, made on Mar 01, 2023. We estimate that they now own 225,808 shares of $BSX, worth an estimated $26.3 million.
Insider Trading at $BSX
There have been a total of 169 insider trades reported at $BSX since 2021, with 25,050 shares purchased and 4.5 million shares sold. The most active insider traders in $BSX stock have been Wendy Carruthers, Jeffrey B. Mirviss, and Michael F Mahoney. The most recent trade was a sale of 4,826 shares reported by Vance R Brown (SVP, GC and Corp. Secretary), made on Feb 21, 2025.
History of Insider Stock Trades by Daniel J. Brennan
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
BSX
|
Sale | 67,333 | Feb 19, 2025 | Feb. 19, 2025, 5:23 p.m. |
|
BSX
|
Sale | 14,630 | Feb 18, 2025 | Feb. 19, 2025, 5:23 p.m. |
|
BSX
|
Sale | 2,900 | Feb 18, 2025 | Feb. 19, 2025, 5:23 p.m. |
|
BSX
|
Sale | 15,087 | Feb 12, 2025 | Feb. 13, 2025, 5:31 p.m. |
|
BSX
|
Sale | 47,621 | May 23, 2024 | May 23, 2024, 4:13 p.m. |
|
BSX
|
Sale | 64,454 | May 22, 2024 | May 23, 2024, 4:13 p.m. |
|
BSX
|
Sale | 13,662 | Feb 20, 2024 | Feb. 20, 2024, 10:03 p.m. |
|
BSX
|
Sale | 30,000 | Mar 02, 2023 | March 2, 2023, 6:01 p.m. |
|
BSX
|
Sale | 75,610 | Mar 01, 2023 | March 2, 2023, 6:01 p.m. |
|
BSX
|
Sale | 7,572 | Feb 15, 2023 | Feb. 16, 2023, 8:15 p.m. |
|
BSX
|
Sale | 11,029 | Mar 02, 2022 | March 3, 2022, 5:24 p.m. |
|
BSX
|
Sale | 53,182 | Feb 22, 2022 | Feb. 23, 2022, 8 p.m. |
|
BSX
|
Sale | 9,136 | Feb 15, 2022 | Feb. 17, 2022, 8:57 p.m. |
|
BSX
|
Sale | 12,187 | Feb 16, 2022 | Feb. 17, 2022, 8:57 p.m. |
$BSX Executives and Stock Owners with Insider Trades
-
Wendy Carruthers, EVP, Human Resources
-
Jeffrey B. Mirviss, EVP&Pres, Periph Intervent
-
Michael F Mahoney, Chairman, President & CEO
-
Daniel J. Brennan, EVP and CFO
-
Arthur C Butcher, EVP& Grp Pres, MedSurg & APAC
-
Joseph Michael Fitzgerald, EVP & Group Pres, Cardiology
-
John Bradley Sorenson, EVP, Global Operations
-
Wendy Carruthers, SVP, Human Resources
-
David A Pierce, EVP Pres MedSurg
-
Jodi Euerle Eddy, SVP, Chief Info & Digital Off.
-
Eric Francis Yves Thepaut, EVP & Pres, Eur, Mid-East, Afr
-
Vance R Brown, SVP, GC and Corp. Secretary
-
Jonathan Monson, VP, Global Controller and CAO
-
Arthur C Butcher, EVP&Pres, Asia Pacific
-
Meghan Scanlon, SVP,Pres,Urology Pelvic Health
-
Scott Olson, SVP & Pres, CRM, Diagnostics
-
Scott Olson, SVP & Pres, Rhythm Management
-
Jonathan Monson, SVP, Global Controller and CAO
-
Ian T Meredith, EVP Global Chief Med Officer
-
John Bradley Sorenson, SVP, Global Supply Chain
-
Emily Woodworth, SVP, Global Controller and CAO
-
Joseph Michael Fitzgerald, EVP & Pres, Interven Cardio
-
Maulik Nanavaty, SVP & Pres, Neuromodulation
-
Edward F Mackey, EVP, Operations
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.